Results 321 to 330 of about 381,364 (391)

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis   +5 more
wiley   +1 more source

Infrequent case of leucoencephalopathy after electric shock trauma. [PDF]

open access: yesRadiol Case Rep
Grisales JE   +5 more
europepmc   +1 more source

The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment. [PDF]

open access: yesOrphanet J Rare Dis
Dallan A   +8 more
europepmc   +1 more source

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

open access: bronze, 1977
Harold O. Conn   +6 more
openalex  

Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma. [PDF]

open access: yesFront Pharmacol
Chen M   +8 more
europepmc   +1 more source

The Role of Proton Magnetic Resonance Spectroscopy in Neonatal and Fetal Brain Research

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
The biochemical composition and structure of the brain are in a rapid change during the exuberant stage of fetal and neonatal development. 1H‐MRS is a noninvasive tool that can evaluate brain metabolites in healthy fetuses and infants as well as those with neurological diseases.
Steve C.N. Hui   +2 more
wiley   +1 more source

Wernicke encephalopathy in a patient with drug-induced liver failure: a case report. [PDF]

open access: yesFront Nutr
Cao JJ   +6 more
europepmc   +1 more source

Expanding the Estimated Fetal Weight Definition of Growth Restriction by Adding Small Abdominal Circumference

open access: yesJournal of Ultrasound in Medicine, EarlyView.
Objective The Society for Maternal‐Fetal Medicine's (SMFM) diagnostic criteria for fetal growth restriction (FGR) recently added abdominal circumference (AC) <10th percentile to estimated fetal weight (EFW) <10th percentile; however, its prediction of neonatal morbidity is unknown.
Ashley Shea   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy